Description

Mounjaro KwikPen 15mg Injection

MOUNJARO KwikPen 15mg Injection is a once-weekly injectable treatment featuring tirzepatide, a dual-action hormone receptor agonist. This KwikPen delivers a potent dose to help adults with type 2 diabetes or obesity achieve optimal blood sugar control and significant weight loss. Designed for ease of home use, the pre-filled pen provides four 15mg doses for convenient self-administration.​

Uses

• Indicated for adults needing advanced glycemic control in type 2 diabetes when lower doses have not achieved target levels.

• Also prescribed to support weight reduction and improve cardiovascular and metabolic health in patients with obesity or weight-related conditions.

• Helps reduce appetite, manage cravings, and promote sustained weight loss alongside lifestyle interventions.​

Precautions

• Start treatment at a lower dose (2.5mg weekly) and gradually increase in 2.5mg increments every 4 weeks to reach the 15mg maintenance dose, which is the maximum recommended dose.

• Injection sites should be rotated between the abdomen, thigh, and upper arm to prevent irritation.

• Common side effects include nausea, vomiting, diarrhea, and constipation, which usually improve over time.

• Not suitable for people with type 1 diabetes or a history of pancreatitis. Consult your doctor before use during pregnancy or breastfeeding.​

FAQs

Q: How often do I inject the 15mg dose?
A: Once weekly, on the same day and time each week, injecting 0.6 ml subcutaneously.​

Q: What if I miss a dose?
A: Administer it as soon as possible within 4 days. If more than 4 days pass, skip the missed dose and continue as usual.​

Q: Who should use the 15mg dose?
A: The 15mg dose is for those who need the maximum glycemic control and weight loss support after titrating from lower doses under medical supervision.​

Q: Are there any special storage instructions?
A: Store unopened pens refrigerated; once in use, pens can be kept at room temperature up to 21 days.​

Interesting Fact

Tirzepatide in MOUNJARO mimics two natural gut hormones (GIP and GLP-1), which is a first in diabetes treatment. This dual mechanism helps optimize insulin secretion, reduce appetite, and enhance weight loss, revolutionizing care for millions worldwide.